The startup operates a healthcare crowdfunding platform that connects investors and individuals with early-stage healthcare companies seeking capital. This platform addresses the funding gap in the healthcare sector, enabling entrepreneurs to secure necessary resources for their innovations.
Funding
$880K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Early-stage healthcare companies often face significant funding gaps, hindering their ability to develop and commercialize innovative solutions. Traditional venture capital can be difficult to access, especially for companies that are not yet generating revenue or have limited traction. This lack of funding can delay or prevent the development of potentially life-saving technologies.
Solution
Bioverge operates a platform that connects accredited investors with early-stage healthcare companies seeking capital. The platform offers individuals, advisors, and institutions the opportunity to invest in curated deals across various healthcare sectors. Bioverge provides access to diversified portfolios of emerging healthcare startups through its Access Funds, allowing investors to participate with a single investment. Alternatively, investors can select individual investment opportunities on a deal-by-deal basis or invest in Thematic Funds focused on specific technology or disease areas.
Target Audience
Bioverge targets accredited investors, including individuals, advisors, and institutions, who are interested in investing in early-stage healthcare companies.
Features
- Access Funds: Diversified portfolios of healthcare startups with a single investment.
- Deal-By-Deal Investing: Select individual investment opportunities.
- Thematic Funds: Focused on specific technology or disease areas like longevity, cancer, and digital health.
- Secondary Market: Potential liquidity options for investments.
- Due Diligence: Investment team leverages domain expertise and network to select deals.
- Accredited Investor Verification: Ensures compliance with SEC regulations.